I want a partnership to mean that someone else takes some of the risk. And takes the lead on P3 trials because MSB's current staff are 0 from 4.
More particularly, risk relating to where all the trials are being done (that is, in the USA with the FDA).
That's what a true partnership means to Mesoblast.
If all partnerships are based on FDA approval, then what are the other BoDs and management doing? If all partnerships are based on FDA approval then all staff should be project/trial based? Rose is the ONLY member of the Board that is involved in trials?
How is any shareholder happy right now? We STILL carry ALL the risk. And the SP just got massively diluted at record lows.
The product we are talking about hasn't changed in years. SI has been spouting talks with Big Pharma for 20 years. And 20 years on and it looks remarkably like MSB has to remove all risk before anyone will partner. That's less partnership and more gifting.
The same guy that brought us the Novartis deal........that wasn't.
Ann: Mesoblast Completes Placement and Entitlement Offer, page-97
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
-0.025(1.86%) |
Mkt cap ! $1.507B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.35 | $1.31 | $2.699M | 2.040M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34995 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 10374 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |